Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.
作者： Peter Grimm , Ignace Billiet , David Bostwick , Adam P. Dicker , Steven Frank
DOI: 10.1111/J.1464-410X.2011.10827.X
关键词:
摘要: … -specific antigen (PSA)-free progression at maximum follow-up for patients with high-risk prostate cancer treated with a range of therapeutic options. The SDE represents 1 SD about the …
elsevier.com
prostata-brachytherapie.ch 参考文章(72)
Gregory S. Merrick, Wayne M. Butler, Robert W. Galbreath, Jonathan Lief, Nathan Bittner, Kent E. Wallner, Edward Adamovich, Prostate cancer death is unlikely in high-risk patients following quality permanent interstitial brachytherapy. BJUI. ,vol. 107, pp. 226- 232 ,(2011) , 10.1111/J.1464-410X.2010.09486.X
Michael J. Zelefsky, Yoshiya Yamada, Marisa A. Kollmeier, Alison M. Shippy, Michelle A. Nedelka, Long-Term Outcome Following Three-Dimensional Conformal/Intensity-Modulated External-Beam Radiotherapy for Clinical Stage T3 Prostate Cancer European Urology. ,vol. 53, pp. 1172- 1179 ,(2008) , 10.1016/J.EURURO.2007.12.030
Richard G. Stock, Jamie A. Cesaretti, Simon J. Hall, Nelson N. Stone, Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy. BJUI. ,vol. 104, pp. 1631- 1636 ,(2009) , 10.1111/J.1464-410X.2009.08661.X
Ryan J. Burri, Alice Y. Ho, Kevin Forsythe, Jamie A. Cesaretti, Nelson N. Stone, Richard G. Stock, Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancer. International Journal of Radiation Oncology Biology Physics. ,vol. 77, pp. 1315- 1321 ,(2010) , 10.1016/J.IJROBP.2009.06.052
Deborah A Kuban, Howard D Thames, Larry B Levy, Eric M Horwitz, Patrick A Kupelian, Alvaro A Martinez, Jeff M Michalski, Thomas M Pisansky, Howard M Sandler, William U Shipley, Michael J Zelefsky, Anthony L Zietman, Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era ☆ International Journal of Radiation Oncology Biology Physics. ,vol. 57, pp. 915- 928 ,(2003) , 10.1016/S0360-3016(03)00632-1
Mark A. Moyad, Gregory S. Merrick, Wayne M. Butler, Kent E. Wallner, Robert W. Galbreath, Brian Kurko, Edward Adamovich, Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer Urology. ,vol. 66, pp. 1150- 1154 ,(2005) , 10.1016/J.UROLOGY.2005.08.053
Marisa A Kollmeier, Richard G Stock, Nelson Stone, Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: Importance of patient selection and implant quality International Journal of Radiation Oncology Biology Physics. ,vol. 57, pp. 645- 653 ,(2003) , 10.1016/S0360-3016(03)00627-8
Nicholas P. Munro, Bashar Al-Qaisieh, Peter Bownes, Jonathan Smith, Brendan Carey, David Bottomley, Dan Ash, Ann M. Henry, Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10years Radiotherapy and Oncology. ,vol. 96, pp. 34- 37 ,(2010) , 10.1016/J.RADONC.2010.03.004
Brett S. Carver, Fernando J. Bianco, Peter T. Scardino, James A. Eastham, Long-Term Outcome Following Radical Prostatectomy in Men With Clinical Stage T3 Prostate Cancer The Journal of Urology. ,vol. 176, pp. 564- 568 ,(2006) , 10.1016/J.JURO.2006.03.093
Michael J. Zelefsky, Deborah A. Kuban, Larry B. Levy, Louis Potters, David C. Beyer, John C. Blasko, Brian J. Moran, Jay P. Ciezki, Anthony L. Zietman, Thomas M. Pisansky, Mohamed Elshaikh, Eric M. Horwitz, Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. International Journal of Radiation Oncology Biology Physics. ,vol. 67, pp. 327- 333 ,(2007) , 10.1016/J.IJROBP.2006.08.056